What question did this study set out to answer?

The objective is to evaluate the effectiveness of anticoagulant therapy in preventing and treating peripheral thromboembolic disease.

October 1, 1951Circulation

Anticoagulant Therapy in Peripheral Vascular Disease

View Full Paper

Ask AI

Bookmark

Population

Patients with peripheral thromboembolic disease

Design

Review

Authors

NBNelson W. BarkerUniversity of Minnesota

Discussion

Member takes

Implication

Supports monitored anticoagulation in thromboembolism; leaves open prospective validation against current standards.

Key Points

The objective is to evaluate the effectiveness of anticoagulant therapy in preventing and treating peripheral thromboembolic disease.
Focused on anticoagulants heparin and dicumarol
Individualized dosage based on coagulation tests
Clinical evaluation of new anticoagulant drugs
Proper use of heparin and dicumarol shows a very small risk of bleeding
New anticoagulant drugs are under clinical evaluation for improved effectiveness and safety

Structured PICO

Population

Patients with peripheral thromboembolic disease

Intervention

Anticoagulant therapy (heparin and dicumarol)

Heparin and dicumarol are effective and safe for managing peripheral thromboembolic disease when dosage is individualized based on coagulation tests.

Cite This Study

Nelson W. Barker (1951) studied this question.

synapsesocial.com/papers/6a20b1d4e2a660d176234937 https://doi.org/10.1161/01.cir.4.4.613

Topics

Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Anticoagulant Therapy in Peripheral Vascular Disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Anticoagulant Therapy in Peripheral Vascular Disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider